Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific, and industrial use. It operates through the following segments: Radiation Therapy, Isotope Products, Radiopharma, and Others. The Radiation Therapy segment concentrates on product development, manufacturing, the market introduction, and the sale of radioactive products for cancer therapy. The Isotope Products segment manufactures and distributes standards and radiation sources for medical and industrial purposes. The Radiopharma segment comprises the device division for synthesis modules and accessories, short-lived radioactive agents imaging using positron emission tomography and longer-lived radioisotopes for pharmaceutical applications. The Others segment contains internal Group services such as radiation protection, accounting, Information Technology, and human resources as well as the processing of production waste. It's also responsible for retrieving, processing, and conditioning low-level radioactive isotope waste from hospitals and other facilities. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany.